-
Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Mar 10, 2025, 14:00 PM -
The Impact of Endoscopic Screening Programs for Gastric Cancer in Japan
Mar 10, 2025, 14:00 PM -
Racial Disparity in Healthcare Expenditure Among Older Adults with Cardiovascular Diseases
Mar 10, 2025, 14:00 PM -
Evaluating Imaging Artificial Intelligence (AI) Matching Real-World Digital Twins (rwDTs) Into an External Control Arm (ECA) for MYSTIC: A Phase 3 Clinical Trial in Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Mar 10, 2025, 14:00 PM -
From Manual to Machine: A Deep Dive into AI-Powered Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR
Mar 10, 2025, 14:00 PM -
Real-world Impact of the United States Preventive Services Task Force (USPSTF) Guidelines on HIV-1 Pre-Exposure Prophylaxis (PrEP) Ancillary Service Cost Sharing: Segmented Change Pre- and Post-Milestone USPSTF Timepoints
Mar 10, 2025, 14:00 PM -
Impact of Cirrhosis on Health-Related Quality of Life and Activity Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada
Mar 10, 2025, 14:00 PM -
Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel
Mar 10, 2025, 14:00 PM -
Hemoglobin Levels and Social Determinants of Health as Risk-factors of End-Organ Damage in Sickle Cell Disease: A Retrospective Analysis
Mar 10, 2025, 14:00 PM -
Physician, Patient and Caregiver Concordance in a Real-World US Generalized Myasthenia Gravis Population
Mar 10, 2025, 14:00 PM -
Transforming Global Value Dossier (GVD) Drafting: Creation with a Generative Artificial Intelligence (Gen AI)-Driven Coauthoring Accelerator
Mar 10, 2025, 14:00 PM -
Real-World Subcutaneous Monoclonal Antibody Use Trends for Oncology in the US
Mar 10, 2025, 14:00 PM -
Real-World Use of Biologics in the Treatment of Psoriasis and Ankylosing Spondylitis in China: The Case of Secukinumab
Mar 10, 2025, 14:00 PM -
Race, Social Determinants of Health (SDoH), and Stage at Breast Cancer Diagnosis in Electronic Health Records (EHR) Data
Mar 10, 2025, 14:00 PM -
Participation in a Patient Support Program is Associated With Improved Access to Efgartigimod Treatment for Generalized Myasthenia Gravis in Patients Facing Social Determinants of Health (SDOH) Challenges
Mar 10, 2025, 14:00 PM -
Impact of Newborn Screening for Duchenne Muscular Dystrophy: A Model-Based Analysis
Mar 10, 2025, 14:00 PM -
How HTA Should Consider the Global Value of Health Products to Support Public Decision?
Mar 10, 2025, 14:00 PM -
Utilization and Impact of GLP-1s: Patient-Reported Healthcare Resource Utilization and Costs in Patients With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Understanding the Caregiver Experience Through an Exploration of the Literature
Mar 10, 2025, 14:00 PM